Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Some safety considerations were noted Participants in the semaglutide group lost on average 5% of their body weight
Crude RRs with 95% CIs were computed using log-binomial regression to compare the proportion of participants experiencing at least one AE or SAE between treatment arms
Debatri Datta Edited By Dr
Researchers reviewing safety information should consider the full adverse event profile, including cardiovascular observations, discontinuation rates, laboratory measures and any serious adverse events reported in trial data
Your healthcare professional may refrain from prescribing Wegovy if you: Do not meet the eligibility criteria for Wegovy (an initial body mass index above 30 kg/m2 or above 27 kg/m2 with at least one weight-related comorbid condition such as high cholesterol, high blood pressure, or high blood glucose)
US$ 23.68
US$ 25.83
US$ 21.32
US$ 24.25
US$ 24.30
US$ 29.02
